Cécile Chartier
Impact in
Papers in
- Oncology 11
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 3
- Cutaneous Melanoma Detection and Management 2
- Co-authors
- Andréa Pavirani (4 shared papers)A Dieterlé (4 shared papers)Majid Mehtali (3 shared papers)Murielle Gantzer (1 shared paper)Eric Degryse (1 shared paper)Austin Gurney (5 shared papers)John Lewicki (5 shared papers)Michael F. Clarke (2 shared papers)
- Journals
- Annals of Oncology (3 papers)PLoS ONE (3 papers)Cancer Research (3 papers)European Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Cécile Chartier
22 papers receiving 1.7k citations
Cécile Chartier's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 816
- Genetics 721
- Molecular Biology 970
- Biotechnology 113
- Cancer Research 171
Countries citing papers authored by Cécile Chartier
This map shows the geographic impact of Cécile Chartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Chartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Chartier more than expected).
Fields of papers citing papers by Cécile Chartier
This network shows the impact of papers produced by Cécile Chartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Chartier. The network helps show where Cécile Chartier may publish in the future.
Co-authors
The 25 scholars most cited alongside Cécile Chartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli Hit paper breakdown → | 1996 | 592 |
| 2 | 2008 | 449 | |
| 3 | 2008 | 155 | |
| 4 | 2003 | 146 | |
| 5 | 2017 | 122 | |
| 6 | 1999 | 48 | |
| 7 | Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. | 1996 | 47 |
| 8 | 2008 | 40 | |
| 9 | Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. | 1996 | 32 |
| 10 | An efficient procedure to select and recover recombinant adenovirus vectors. | 1995 | 23 |
| 11 | 2006 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2005 | 12 | |
| 14 | The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice. | 1992 | 10 |
| 15 | D.N.C.B. for malignant melanoma: significance in the treatment strategy. | 1990 | 9 |
| 16 | 2020 | 7 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2004 | 2 |
About Cécile Chartier
Cécile Chartier is a scholar working on Oncology, Molecular Biology, Genetics, Immunology and Biotechnology, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Virus-based gene therapy research (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Research and Treatments (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (816 citations), Genetics (721 citations), Molecular Biology (970 citations), Biotechnology (113 citations) and Cancer Research (171 citations). Cécile Chartier has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Andréa Pavirani, A Dieterlé, Majid Mehtali, Murielle Gantzer, Eric Degryse, Austin Gurney, John Lewicki, Michael F. Clarke, Stephanie Smith‐Berdan and Jorge Aguilar. Their work appears in journals such as Annals of Oncology, PLoS ONE, Cancer Research, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.